

fda-agency-news
BASIC Member

-
Supreme Service Solutions LLC Voluntarily Recalls Supreme Vegetable Products Because of Possible Health Risk
Supreme Service Solutions LLC. (dba Supreme Produce) is assisting in a Kroger Store recall for items purchased from Bedner Growers Inc. (purchased from Kroger and its affiliates ) due to possible…
-
Publix Voluntarily Recalls GreenWise Pear, Kiwi, Spinach & Pea Baby Food Pouches Due to Lead
LAKELAND, Fla, May 9, 2025 – Publix Super Markets, Inc. has initiated a voluntary recall of GreenWise Pear, Kiwi, Spinach & Pea Baby Food, produced by Bowman Andros LLC and distributed to Publix grocery stores…
-
Ray & Mascari Inc. Recalls 4 Count Vine Ripe Tomatoes Because of Possible Health Risk
Ray & Mascari Inc. of Indianapolis, Indiana, is recalling 4 Count Vine Ripe Tomatoes packaged in clam shell containers [20 oz. (1 lb. 4 oz) 567g] with UPC# 7 96553 20062 1, and a master case label with…
-
Williams Farms Repack LLC Recalls Tomatoes Due to Possible Salmonella Contamination
Williams Farms Repack LLC is recalling Tomatoes sizes; 4×5 2 layer, 60ct 2layer, 3ct trays in the Williams Farms Repack label, and 5×6 25lb, 6×6 25lb H&C Farms Label, due to a potential contamination…
-
Patient Listening Session Summaries
Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Public Engagement Staff draft summaries for FDA-requested sessions and the…
-
Requesting an FDA Patient-Led Listening Session
Learn about how to request a Patient Listening Session with the FDA to share your experiences and perspectives.
-
Suggested Sample Agenda for an FDA Patient-Led Listening Session
View a suggested sample agenda an FDA Patient-Led Listening Session
-
Planning an FDA Patient-Led Listening Session
Learn the steps for planning an FDA Patient-Led Listening Session.
-
Preparing Patient and Caregiver Participants for an FDA Patient-Led Listening Session and Suggested Topics
Learn about topics that are outside of the scope of FDA’s work and suggested topics for FDA-Patient-Led Listening Sessions.
-
Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
This is the Draft Guidance for Industry – Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
- Load More